FDA Inspection
Contacare Ophthalmics & DiagnosticsContacare Ophthalmics & Diagnostics – FDA Inspection, Apr 4, 2017
Record Details
This FDA Inspection record concerns Contacare Ophthalmics & Diagnostics, with an inspection on April 4, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · efe30888-480f-4f4c-8ae1-03fd02579d6c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1014705
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
- 21 CFR 211.68(a)Written calibration / inspection records not kept
- 21 CFR 211.130(a)Prevention of cross contamination, mix-ups
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Contacare Ophthalmics & Diagnostics
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 1, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 29, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Contacare Ophthalmics & Diagnostics
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.